Related references
Note: Only part of the references are listed.HER2-targeted therapies - a role beyond breast cancer
Do-Youn Oh et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
High-Throughput Cellular Thermal Shift Assays in Research and Drug Discovery
Mark J. Henderson et al.
SLAS DISCOVERY (2020)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer
Lei Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identifying drug targets in tissues and whole blood with thermal-shift profiling
Jessica Perrin et al.
NATURE BIOTECHNOLOGY (2020)
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
Punit Saraon et al.
NATURE CHEMICAL BIOLOGY (2020)
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Alexander Drilon et al.
NATURE MEDICINE (2020)
FGF2 alters macrophage polarization, tumour immunity and growth and can be targeted during radiotherapy
Jae Hong Im et al.
NATURE COMMUNICATIONS (2020)
Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma Radiosensitivity
Marta Baro et al.
CLINICAL CANCER RESEARCH (2019)
Bioluminescence resonance energy transfer-based imaging of protein-protein interactions in living cells
Hiroyuki Kobayashi et al.
NATURE PROTOCOLS (2019)
Selective inhibition of N-linked glycosylation impairs receptor tyrosine kinase processing
Elsenoor Klaver et al.
DISEASE MODELS & MECHANISMS (2019)
Single and Dual Targeting of Mutant EGFR with an Allosteric Inhibitor
Ciric To et al.
CANCER DISCOVERY (2019)
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
George M. Burslem et al.
CANCER RESEARCH (2019)
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Dynamin inhibitors impair platelet-derived growth factor β-receptor dimerization and signaling
Johan Heldin et al.
EXPERIMENTAL CELL RESEARCH (2019)
The Transcriptional Roles of ALK Fusion Proteins in Tumorigenesis
Stephen P. Ducray et al.
CANCERS (2019)
Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation
Mahlet Z. Tamirat et al.
PLOS ONE (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Functional recruitment of dynamin requires multimeric interactions for efficient endocytosis
Morgane Rosendale et al.
NATURE COMMUNICATIONS (2019)
Targeting FLT3 mutations in AML: review of current knowledge and evidence
Naval Daver et al.
LEUKEMIA (2019)
Fibroblast growth factor receptors as treatment targets in clinical oncology
Masaru Katoh
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The pharmacology and therapeutic applications of monoclonal antibodies
Maria Sofia Castelli et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
Targeting the Golgi apparatus to overcome acquired resistance of non-small cell lung cancer cells to EGFR tyrosine kinase inhibitors
Yoshimi Ohashi et al.
ONCOTARGET (2018)
Crystal structure of EGFR T790M/C797S/V948R in complex with EAI045
Peng Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors
Ludovic Menard et al.
CANCER RESEARCH (2018)
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase Inhibitors
Cecilia Lopez Sambrooks et al.
CANCER RESEARCH (2018)
Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis
Mikhail M. Savitski et al.
CELL (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
NanoBRET Approaches to Study Ligand Binding to GPCRs and RTKs
Leigh A. Stoddart et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Homogeneous Assay for Target Engagement Utilizing Bioluminescent Thermal Shift
Melanie L. Dart et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Enhancing Antiproliferative Activity and Selectivity of a FLT-3 Inhibitor by Proteolysis Targeting Chimera Conversion
George M. Burslem et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
Philipp M. Cromm et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
NTRK fusion-positive cancers and TRK inhibitor therapy
Emiliano Cocco et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Paolo M. Comoglio et al.
NATURE REVIEWS CANCER (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
George M. Burslem et al.
CELL CHEMICAL BIOLOGY (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
Systematic Identification of Oncogenic EGFR Interaction Partners
Julia Petschnigg et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Broad-Spectrum Kinase Profiling in Live Cells with Lysine-Targeted Sulfonyl Fluoride Probes
Qian Zhao et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2017)
A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome
Zhong Yao et al.
MOLECULAR CELL (2017)
Real-time analysis of the binding of fluorescent VEGF165a to VEGFR2 in living cells: Effect of receptor tyrosine kinase inhibitors and fate of internalized agonist-receptor complexes
Laura E. Kilpatrick et al.
BIOCHEMICAL PHARMACOLOGY (2017)
Insulator dysfunction and oncogene activation in IDH mutant gliomas
William A. Flavahan et al.
NATURE (2016)
Activation Mechanism of Oncogenic Deletion Mutations in BRAF, EGFR, and HER2
Scott A. Foster et al.
CANCER CELL (2016)
M-COPA, a Golgi Disruptor, Inhibits Cell Surface Expression of MET Protein and Exhibits Antitumor Activity against MET-Addicted Gastric Cancers
Yoshimi Ohashi et al.
CANCER RESEARCH (2016)
Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation
Christopher J. Tape et al.
CELL (2016)
Signal processing by the endosomal system
Roberto Villasenor et al.
CURRENT OPINION IN CELL BIOLOGY (2016)
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases
Ying-Nan P. Chen et al.
NATURE (2016)
Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors
Yong Jia et al.
NATURE (2016)
Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells
Cecilia Lopez-Sambrooks et al.
NATURE CHEMICAL BIOLOGY (2016)
Recurrent MET fusion genes represent a drug target in pediatric glioblastoma
Sebastian Bender et al.
NATURE MEDICINE (2016)
The use of cellular thermal shift assay (CETSA) to study Crizotinib resistance in ALK-expressing human cancers
Abdulraheem Alshareef et al.
SCIENTIFIC REPORTS (2016)
NanoBRET-A Novel BRET Platform for the Analysis of Protein-Protein Interactions
Thomas Machleidt et al.
ACS CHEMICAL BIOLOGY (2015)
Insulin/receptor binding: The last piece of the puzzle?
Pierre De Meyts
BIOESSAYS (2015)
Paracrine Effect of NRG1 and HGF Drives Resistance to MEK Inhibitors in Metastatic Uveal Melanoma
Hanyin Cheng et al.
CANCER RESEARCH (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M
Kenneth S. Thress et al.
NATURE MEDICINE (2015)
Regulation of EGFR signal transduction by analogue-to-digital conversion in endosomes
Roberto Villasenor et al.
ELIFE (2015)
Different Epidermal Growth Factor (EGF) Receptor Ligands Show Distinct Kinetics and Biased or Partial Agonism for Homodimer and Heterodimer Formation
Jennifer L. Macdonald-Obermann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
The mammalian-membrane two-hybrid assay (MaMTH) for probing membrane-protein interactions in human cells
Julia Petschnigg et al.
NATURE METHODS (2014)
Synthesis of the Pitstop family of clathrin inhibitors
Mark J. Robertson et al.
NATURE PROTOCOLS (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
Tracking cancer drugs in living cells by thermal profiling of the proteome
Mikhail M. Savitski et al.
SCIENCE (2014)
RET revisited: expanding the oncogenic portfolio
Lois M. Mulligan
NATURE REVIEWS CANCER (2014)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered
Hui K. Gan et al.
FEBS JOURNAL (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Bypass Mechanisms of Resistance to Receptor Tyrosine Kinase Inhibition in Lung Cancer
Matthew J. Niederst et al.
SCIENCE SIGNALING (2013)
Endocytosis of Receptor Tyrosine Kinases
Lai Kuan Goh et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Endocytosis and Cancer
Ira Mellman et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia
Alex Kentsis et al.
NATURE MEDICINE (2012)
Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma
Devendra Singh et al.
SCIENCE (2012)
Rescue Screens with Secreted Proteins Reveal Compensatory Potential of Receptor Tyrosine Kinases in Driving Cancer Growth
Fred Harbinski et al.
CANCER DISCOVERY (2012)
Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition
Lisa von Kleist et al.
CELL (2011)
A direct role for Met endocytosis in tumorigenesis
Carine Joffre et al.
NATURE CELL BIOLOGY (2011)
Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R
Kerrington R. Molhoek et al.
MELANOMA RESEARCH (2011)
A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
Carla Lucia Esposito et al.
PLOS ONE (2011)
COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport
Ying-Nai Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC
Alexa B. Turke et al.
CANCER CELL (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Molecular Imaging of N-linked Glycosylation Suggests Glycan Biosynthesis Is a Novel Target for Cancer Therapy
Joseph N. Contessa et al.
CLINICAL CANCER RESEARCH (2010)
Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@
Byung Min Chung et al.
BMC CELL BIOLOGY (2009)
Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Lynette M. Sholl et al.
CANCER RESEARCH (2009)
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
Ji Luo et al.
CELL (2009)
Mislocalized Activation of Oncogenic RTKs Switches Downstream Signaling Outcomes
Chunaram Choudhary et al.
MOLECULAR CELL (2009)
Endocytosis and signalling: intertwining molecular networks
Alexander Sorkin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells
Joseph N. Contessa et al.
CANCER RESEARCH (2008)
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Activating Mutations
Seiji Yano et al.
CANCER RESEARCH (2008)
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway
Marie Dance et al.
CELLULAR SIGNALLING (2008)
Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting
Kristian Pietras et al.
PLOS MEDICINE (2008)
Oncogenic activation of the Met receptor tyrosine kinase fusion protein, Tpr-Met, involves exclusion from the endocytic degradative pathway
H. H. L. Mak et al.
ONCOGENE (2007)
Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling
K. Shtiegman et al.
ONCOGENE (2007)
Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
Manabu Soda et al.
NATURE (2007)
Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity
Cai-Hong Yun et al.
CANCER CELL (2007)
Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia
Taranjit S. Gujral et al.
CANCER RESEARCH (2006)
Dynasore, a cell-permeable inhibitor of dynamin
Eric Macia et al.
DEVELOPMENTAL CELL (2006)
Tumor-driven paracrine platelet-derived growth factor receptor α signaling is a key determinant of stromal cell recruitment in a model of human lung carcinoma
ML Tejada et al.
CLINICAL CANCER RESEARCH (2006)
Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1
B Zsebik et al.
IMMUNOLOGY LETTERS (2006)
EGFR gene amplification in breast cancer:: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
R Bhargava et al.
MODERN PATHOLOGY (2005)
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway
HW Lo et al.
CANCER CELL (2005)
The structural basis for autoinhibition of FLT3 by the juxtamembrane domain
J Griffith et al.
MOLECULAR CELL (2004)
Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
A Citri et al.
EMBO REPORTS (2004)
Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3
CHB Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Oncogenic targeting of an activated tyrosine kinase to the Golgi apparatus in a glioblastoma
A Charest et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Nuclear localization of EGF receptor and its potential new role as a transcription factor
SY Lin et al.
NATURE CELL BIOLOGY (2001)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
